Reinstitutionalizing the evaluation of medicines: EU-national complementarities, competition and contradictions
http://www.ecprnet.eu/conferences/general_conference/reykjavik/ At least throughout developed countries, the pharmaceutical industry is in the midst of a period of doubts, reflexion and propositions for change concerning the inextricable link between its economic structure and its political ordering...
Main Authors: | , , |
---|---|
Other Authors: | , , , , |
Format: | Conference Object |
Language: | English |
Published: |
HAL CCSD
2011
|
Subjects: | |
Online Access: | https://shs.hal.science/halshs-00631394 https://shs.hal.science/halshs-00631394/document https://shs.hal.science/halshs-00631394/file/gedipharmaECPR.pdf |
id |
ftunivnantes:oai:HAL:halshs-00631394v1 |
---|---|
record_format |
openpolar |
spelling |
ftunivnantes:oai:HAL:halshs-00631394v1 2023-05-15T16:51:01+02:00 Reinstitutionalizing the evaluation of medicines: EU-national complementarities, competition and contradictions Gorry, Philippe Montalban, Matthieu Smith, Andy Groupe de Recherche en Economie Théorique et Appliquée (GREThA) Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS) Centre Émile Durkheim (CED) Sciences Po Bordeaux - Institut d'études politiques de Bordeaux (IEP Bordeaux)-Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS) Fondation Nationale des Sciences Politiques FNSP Reykjavik, Iceland 2011-08-25 https://shs.hal.science/halshs-00631394 https://shs.hal.science/halshs-00631394/document https://shs.hal.science/halshs-00631394/file/gedipharmaECPR.pdf en eng HAL CCSD halshs-00631394 https://shs.hal.science/halshs-00631394 https://shs.hal.science/halshs-00631394/document https://shs.hal.science/halshs-00631394/file/gedipharmaECPR.pdf info:eu-repo/semantics/OpenAccess 6th ECPR General Conference https://shs.hal.science/halshs-00631394 6th ECPR General Conference, Aug 2011, Reykjavik, Iceland evaluation medicines politic European Union pharmaceutical industry industrie pharmaceutique Union européenne médicaments politique [SHS.SCIPO]Humanities and Social Sciences/Political science info:eu-repo/semantics/conferenceObject Conference papers 2011 ftunivnantes 2023-03-08T00:16:55Z http://www.ecprnet.eu/conferences/general_conference/reykjavik/ At least throughout developed countries, the pharmaceutical industry is in the midst of a period of doubts, reflexion and propositions for change concerning the inextricable link between its economic structure and its political ordering. - From the angle of industrial economics and the business models of firms, the end of the 'blockbuster era' -caused by a plateau in scientific innovation and increased competition from generics- has yet to give rise to a replacement wherein biotechnologies, personalized medicines and preventive clinical practice might eventually herald a new set of parameters; - At the same time, this disruption of the economy of pharmaceuticals has in part of course been caused by decisions by collective and public bodies that have led to greater competition through the lifting of barriers to international trade and encouraging the substitution of off-patented drugs by generics. Whether these measures have been the result of neoliberal ideology, or simply of a drive to cut the ever-rising costs of health care, the consequence has been a challenge to the capacity of large pharmaceutical companies ('Big Pharma') to demand that public and collective bodies reward all the 'innovations' they seek to put on the market (Montalban, 2007 & 2008). Conference Object Iceland Université de Nantes: HAL-UNIV-NANTES |
institution |
Open Polar |
collection |
Université de Nantes: HAL-UNIV-NANTES |
op_collection_id |
ftunivnantes |
language |
English |
topic |
evaluation medicines politic European Union pharmaceutical industry industrie pharmaceutique Union européenne médicaments politique [SHS.SCIPO]Humanities and Social Sciences/Political science |
spellingShingle |
evaluation medicines politic European Union pharmaceutical industry industrie pharmaceutique Union européenne médicaments politique [SHS.SCIPO]Humanities and Social Sciences/Political science Gorry, Philippe Montalban, Matthieu Smith, Andy Reinstitutionalizing the evaluation of medicines: EU-national complementarities, competition and contradictions |
topic_facet |
evaluation medicines politic European Union pharmaceutical industry industrie pharmaceutique Union européenne médicaments politique [SHS.SCIPO]Humanities and Social Sciences/Political science |
description |
http://www.ecprnet.eu/conferences/general_conference/reykjavik/ At least throughout developed countries, the pharmaceutical industry is in the midst of a period of doubts, reflexion and propositions for change concerning the inextricable link between its economic structure and its political ordering. - From the angle of industrial economics and the business models of firms, the end of the 'blockbuster era' -caused by a plateau in scientific innovation and increased competition from generics- has yet to give rise to a replacement wherein biotechnologies, personalized medicines and preventive clinical practice might eventually herald a new set of parameters; - At the same time, this disruption of the economy of pharmaceuticals has in part of course been caused by decisions by collective and public bodies that have led to greater competition through the lifting of barriers to international trade and encouraging the substitution of off-patented drugs by generics. Whether these measures have been the result of neoliberal ideology, or simply of a drive to cut the ever-rising costs of health care, the consequence has been a challenge to the capacity of large pharmaceutical companies ('Big Pharma') to demand that public and collective bodies reward all the 'innovations' they seek to put on the market (Montalban, 2007 & 2008). |
author2 |
Groupe de Recherche en Economie Théorique et Appliquée (GREThA) Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS) Centre Émile Durkheim (CED) Sciences Po Bordeaux - Institut d'études politiques de Bordeaux (IEP Bordeaux)-Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS) Fondation Nationale des Sciences Politiques FNSP |
format |
Conference Object |
author |
Gorry, Philippe Montalban, Matthieu Smith, Andy |
author_facet |
Gorry, Philippe Montalban, Matthieu Smith, Andy |
author_sort |
Gorry, Philippe |
title |
Reinstitutionalizing the evaluation of medicines: EU-national complementarities, competition and contradictions |
title_short |
Reinstitutionalizing the evaluation of medicines: EU-national complementarities, competition and contradictions |
title_full |
Reinstitutionalizing the evaluation of medicines: EU-national complementarities, competition and contradictions |
title_fullStr |
Reinstitutionalizing the evaluation of medicines: EU-national complementarities, competition and contradictions |
title_full_unstemmed |
Reinstitutionalizing the evaluation of medicines: EU-national complementarities, competition and contradictions |
title_sort |
reinstitutionalizing the evaluation of medicines: eu-national complementarities, competition and contradictions |
publisher |
HAL CCSD |
publishDate |
2011 |
url |
https://shs.hal.science/halshs-00631394 https://shs.hal.science/halshs-00631394/document https://shs.hal.science/halshs-00631394/file/gedipharmaECPR.pdf |
op_coverage |
Reykjavik, Iceland |
genre |
Iceland |
genre_facet |
Iceland |
op_source |
6th ECPR General Conference https://shs.hal.science/halshs-00631394 6th ECPR General Conference, Aug 2011, Reykjavik, Iceland |
op_relation |
halshs-00631394 https://shs.hal.science/halshs-00631394 https://shs.hal.science/halshs-00631394/document https://shs.hal.science/halshs-00631394/file/gedipharmaECPR.pdf |
op_rights |
info:eu-repo/semantics/OpenAccess |
_version_ |
1766041134296989696 |